U.S. Genetic Testing Market Share, Globe Key Updates, Demand, Size, and Industry Forecast 2023-2027.

The U.S. genetic testing market is a rapidly growing segment of the healthcare industry that offers a range of services aimed at detecting genetic variations that may be associated with disease risk, diagnosis, and treatment. Genetic testing can be used to identify inherited genetic mutations, detect somatic mutations in cancer cells, and screen for potential drug interactions.

The market is driven by factors such as the growing prevalence of genetic disorders, increasing demand for personalized medicine, and advancements in genetic testing technologies. The market includes a range of players, including large diagnostic companies, biotechnology firms, and specialized genetic testing laboratories.

See the detailed report:


The global “U.S. Genetic Testing Market” size is expected to reach USD 10.29 billion by 2027, exhibiting a CAGR of 13.0% during the forecast period, states Fortune Business Insights in a report titled “U.S. Genetic Testing Market, 2023-2027.” The market size stood at USD 4.11 billion in 2019.

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • Key Opinion Leaders associated with Infinium Global Research
  • Internal and External subject matter experts
  • Professionals and participants from the industry

What is the goal of the report?

  • The market report presents the estimated size of the market at the end of the forecast period. The report also examines historical and current market sizes.
  • During the forecast period, the report analyses the growth rate, market size, and market valuation.
  • The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets.
  • The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance

List of Key Players Profiled in the Report:

  • BioReference Laboratories, Inc. (Elmwood Park, U.S.)
  • Progenity, Inc. (San Diego, U.S.)
  • Quest Diagnostics Incorporated (Secaucus, U.S.)
  • Myriad Genetics, Inc. (Salt Lake City, U.S.)
  • Fulgent Genetics (Temple City, U.S.)
  • Burning Rock Biotech Limited (Guangzhou, China)

To get more information on the regional analysis of this market, Request a Free sample:


Reasons for buying this report:

  • It offers an analysis of changing competitive scenario.
  • For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
  • Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
  • It offers regional analysis of U.S. Genetic Testing Market along with business profiles of several stakeholders.
  • It offers five-year assessment of this market.
  • It helps in understanding the major key product segments.
  • It offers massive data about trending factors that will influence the progress of the Market

Table of content:

  • Introduction

o Research Scope

o Market Segmentation

o Research Methodology

o Definitions and Assumptions

  • Executive Summary
  • Market Dynamics

o Market Drivers

o Market Restraints

o Market Opportunities

o Market Trends


About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Posted in Business News on April 25 at 01:15 PM

Comments (0)

No login